ArticleScience translational medicine2026

Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.

Xiaopeng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.